200 related articles for article (PubMed ID: 24819397)
1. Structure of the p300 histone acetyltransferase bound to acetyl-coenzyme A and its analogues.
Maksimoska J; Segura-Peña D; Cole PA; Marmorstein R
Biochemistry; 2014 Jun; 53(21):3415-22. PubMed ID: 24819397
[TBL] [Abstract][Full Text] [Related]
2. Probing the reaction coordinate of the p300/CBP histone acetyltransferase with bisubstrate analogs.
Karukurichi KR; Cole PA
Bioorg Chem; 2011 Feb; 39(1):42-7. PubMed ID: 21111442
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.
Lasko LM; Jakob CG; Edalji RP; Qiu W; Montgomery D; Digiammarino EL; Hansen TM; Risi RM; Frey R; Manaves V; Shaw B; Algire M; Hessler P; Lam LT; Uziel T; Faivre E; Ferguson D; Buchanan FG; Martin RL; Torrent M; Chiang GG; Karukurichi K; Langston JW; Weinert BT; Choudhary C; de Vries P; Van Drie JH; McElligott D; Kesicki E; Marmorstein R; Sun C; Cole PA; Rosenberg SH; Michaelides MR; Lai A; Bromberg KD
Nature; 2017 Oct; 550(7674):128-132. PubMed ID: 28953875
[TBL] [Abstract][Full Text] [Related]
4. The structural basis of protein acetylation by the p300/CBP transcriptional coactivator.
Liu X; Wang L; Zhao K; Thompson PR; Hwang Y; Marmorstein R; Cole PA
Nature; 2008 Feb; 451(7180):846-50. PubMed ID: 18273021
[TBL] [Abstract][Full Text] [Related]
5. Analysis of p300/CBP histone acetyltransferase regulation using circular permutation and semisynthesis.
Karukurichi KR; Wang L; Uzasci L; Manlandro CM; Wang Q; Cole PA
J Am Chem Soc; 2010 Feb; 132(4):1222-3. PubMed ID: 20063892
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for acyl-group discrimination by human Gcn5L2.
Ringel AE; Wolberger C
Acta Crystallogr D Struct Biol; 2016 Jul; 72(Pt 7):841-8. PubMed ID: 27377381
[TBL] [Abstract][Full Text] [Related]
7. Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP.
Tang Y; Holbert MA; Wurtele H; Meeth K; Rocha W; Gharib M; Jiang E; Thibault P; Verreault A; Cole PA; Marmorstein R
Nat Struct Mol Biol; 2008 Jul; 15(7):738-45. PubMed ID: 18568037
[TBL] [Abstract][Full Text] [Related]
8. Structure of the GCN5 histone acetyltransferase bound to a bisubstrate inhibitor.
Poux AN; Cebrat M; Kim CM; Cole PA; Marmorstein R
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14065-70. PubMed ID: 12391296
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of the p300 acetyltransferase domain: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity.
Bordoli L; Hüsser S; Lüthi U; Netsch M; Osmani H; Eckner R
Nucleic Acids Res; 2001 Nov; 29(21):4462-71. PubMed ID: 11691934
[TBL] [Abstract][Full Text] [Related]
10. Role of the CBP catalytic core in intramolecular SUMOylation and control of histone H3 acetylation.
Park S; Stanfield RL; Martinez-Yamout MA; Dyson HJ; Wilson IA; Wright PE
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):E5335-E5342. PubMed ID: 28630323
[TBL] [Abstract][Full Text] [Related]
11. Application of a fluorescent histone acetyltransferase assay to probe the substrate specificity of the human p300/CBP-associated factor.
Trievel RC; Li FY; Marmorstein R
Anal Biochem; 2000 Dec; 287(2):319-28. PubMed ID: 11112280
[TBL] [Abstract][Full Text] [Related]
12. Differences in specificity and selectivity between CBP and p300 acetylation of histone H3 and H3/H4.
Henry RA; Kuo YM; Andrews AJ
Biochemistry; 2013 Aug; 52(34):5746-59. PubMed ID: 23862699
[TBL] [Abstract][Full Text] [Related]
13. Catalytic mechanism of histone acetyltransferase p300: from the proton transfer to acetylation reaction.
Zhang X; Ouyang S; Kong X; Liang Z; Lu J; Zhu K; Zhao D; Zheng M; Jiang H; Liu X; Marmorstein R; Luo C
J Phys Chem B; 2014 Feb; 118(8):2009-19. PubMed ID: 24521098
[TBL] [Abstract][Full Text] [Related]
14. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
Sagar V; Zheng W; Thompson PR; Cole PA
Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
[TBL] [Abstract][Full Text] [Related]
15. Structure of p300 in complex with acyl-CoA variants.
Kaczmarska Z; Ortega E; Goudarzi A; Huang H; Kim S; Márquez JA; Zhao Y; Khochbin S; Panne D
Nat Chem Biol; 2017 Jan; 13(1):21-29. PubMed ID: 27820805
[TBL] [Abstract][Full Text] [Related]
16. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.
Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T
J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA.
Deng L; Wang D; de la Fuente C; Wang L; Li H; Lee CG; Donnelly R; Wade JD; Lambert P; Kashanchi F
Virology; 2001 Oct; 289(2):312-26. PubMed ID: 11689053
[TBL] [Abstract][Full Text] [Related]
18. Investigation of activation mechanism and conformational stability of
Sivanandam M; Manjula S; Kumaradhas P
J Biomol Struct Dyn; 2019 Sep; 37(15):4006-4018. PubMed ID: 30301423
[TBL] [Abstract][Full Text] [Related]
19. The coactivators CBP/p300 and the histone chaperone NAP1 promote transcription-independent nucleosome eviction at the HTLV-1 promoter.
Sharma N; Nyborg JK
Proc Natl Acad Sci U S A; 2008 Jun; 105(23):7959-63. PubMed ID: 18523016
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the acetylation mechanism by GCN5 histone acetyltransferase.
Jiang J; Lu J; Lu D; Liang Z; Li L; Ouyang S; Kong X; Jiang H; Shen B; Luo C
PLoS One; 2012; 7(5):e36660. PubMed ID: 22574209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
